It has been shown that GRh2 inhibits angiogenesis by reducing the expression of JAM, CD31, vascular endothelial growth factor (VEGF), platelet-derived growth factor, and CNNM1 in cancer cells, thereby inhibiting tumor growth (Huang et al., 2019). This evidence concerns the gene VEGFA and cancer.